NCT00259103View on ClinicalTrials.gov

Recombinant Human Relaxin (rhRlx) in Pregnant Women Scheduled for Induction of Labor

PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions
Labor, Induced
Interventions
DRUG

Serelaxin

DRUG

Placebo

Trial Locations (3)

199034

Evidence CPR, Saint Petersburg

Unknown

Novosibirsk State Medical Academy, Novosibirsk

D.O. Ott Research Institute of Obstetrics and Gynecology, Saint Petersburg

All Listed Sponsors
lead

Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies

INDUSTRY

NCT00259103 - Recombinant Human Relaxin (rhRlx) in Pregnant Women Scheduled for Induction of Labor | Biotech Hunter | Biotech Hunter